A headshot of Daniel Grossman

Daniel Grossman, MD

ANSIRH Director and Professor
[email protected]

Daniel Grossman, MD, is ANSIRH's Director. He focuses his research on both clinical and social science studies aimed at improving access to contraception and safe abortion in the United States, Latin America, and sub-Saharan Africa. He has served on committees for professional organizations such as the American Public Health Association and the American College of Obstetricians and Gynecologists. Dr. Grossman is Vice Chair of Advocacy in the Department of Obstetrics, Gynecology and Reproductive Sciences at UCSF and performs clinical work at Zuckerberg San Francisco General Hospital. He is also a Senior Advisor with Ibis Reproductive Health. Dr. Grossman received his Bachelor of Science in Molecular Biophysics and Biochemistry from Yale University and an MD from Stanford University. He completed his residency in Obstetrics and Gynecology at UCSF.

Citations
  • Merz-Herrala AA, Biggs MA, Ehrenreich K, Kaller S, Ralph LJ, Scott KA, Kapp N, Kromenaker T, Perritt J, Kari White, Grossman D. Examining the association between prior medical mistreatment and interest in and support for over-the-counter medication abortion among people seeking in-person abortion in the United States. BMC Health Services Research. April 2026; https://doi.org/10.1186/s12913-026-14505-2.
  • Baba F, Ralph LJ, Biggs MA, McNicholas C, Miller AH, Grossman D. Satisfaction with and Feasibility of No-Test Telehealth Medication Abortion vs In-Person Care with Ultrasound in the United States. Contraception. April 2026; https://doi.org/10.1016/j.contraception.2026.111459.
  • Ralph LJ, Baba F, Ehrenreich K, Natalie Morris, MPH, Biggs MA, Blanchard K, Hernández E, Kapp N, Kromenaker T, Perritt J, Raymond EG, Kari White, Grossman D. Accuracy of Self-Selection for Medication Abortion Using a Prototype Drug Facts Label. JAMA Internal Medicine. April 2026; https://doi.org/10.1001/jamainternmed.2026.0298.
  • Ehrenreich K, Biggs MA, Kaller S, Ralph LJ, Blanchard K, Bustamante CK, Cervantes M, Hauser D, Hernández E, Kapp N, Kromenaker T, Moayedi G, Perritt J, Raymond EG, Kari White, Grossman D. Development of a consumer information leaflet for a prototype over-the-counter mifepristone and misoprostol medication abortion product. Contraception. January 2026; https://doi.org/10.1016/j.contraception.2025.111361.
  • Nichols V, Maske A, Elliott R, Wahlin B, Blanchard K, Leong L, Rafie S, Grossman D, Schenk L, Nelson B, Downing D, Lin J, Cleland K, Robinson-Flint J, Hauser D. Lessons learned from the movement behind the first over-the-counter daily birth control pill in the United States and recommended strategies for implementing full insurance coverage. Contraception. December 2025; https://doi.org/10.1016/j.contraception.2025.111348.
  • Brander C, Grindlay K, Grossman D, Zuniga C. An exploratory study of patients’ experiences with and reasons for using one virtual-only telecontraceptive platform in the United States in 2020–2021. Reproductive Health. December 2025; https://doi.org/10.1186/s12978-025-02181-0.
  • Grindlay K, Key K, McDonald-Mosley R, Kottke M, Diallo DD, Gulati M, Grossman D. Over-the-counter access to combined oral contraceptives for individuals with hypertension: an expert review. American Journal of Preventive Cardiology. October 2025; https://doi.org/10.1016/j.ajpc.2025.101328.
  • Biggs MA, Armstrong MA, Tucker L, Kaller S, Rabbani J, Lee JW, Chillemi G, Grossman D. Incidence of Ectopic Pregnancy and Diagnostic Accuracy of Ectopic Pregnancy Screening Criteria Among People Seeking Versus Not Seeking Abortion: A Retrospective Case-Control Study. Women's Health Issues. October 2025; https://doi.org/10.1016/j.whi.2025.08.006.
  • Nagle A, Beasley A, Lerma K, Sierra G, Pérez GA, Grossman D, Kari White. Preferred strategies for obtaining abortion care among pregnant Texans: A latent class analysis. Contraception. October 2025; https://doi.org/10.1016/j.contraception.2025.111244.
  • Natalie Morris, MPH, Biggs MA, Grossman D. Pharmacist Dispensing of Mifepristone: Evaluation of Knowledge and Support Before and After a Continuing Education Course. Pharmacy. September 2025; https://doi.org/10.3390/pharmacy13050131.
  • Watson K, Grossman D, Ehrenreich K, Biggs MA, Ralph LJ. Assessing Comprehension of Informed Consent in Abortion Research. Contraception. August 2025; https://doi.org/10.1016/j.contraception.2025.111051.
  • Grossman D, Chung E. Evidence Supports Removing Restrictions on Mifepristone. JAMA. June 2025; https://doi.org/10.1001/jama.2025.8138.
  • Biggs MA, Baba F, Ralph LJ, Schroeder R, McNicholas C, Miller AH, Grossman D. Psychosocial burden when accessing medication abortion when using no-test telehealth care compared to in-person care with ultrasound. Contraception. March 2025; https://doi.org/10.1016/j.contraception.2025.110894.
  • Biggs MA, Ralph LJ, Ehrenreich K, Kaller S, Blanchard K, Hauser D, Kapp N, Kromenaker T, Moayedi G, Perritt J, Raymond EG, Kari White, Grossman D. No-Test Screening Protocols May Disproportionately Exclude Structurally Oppressed Communities Who Could Benefit from Accessing Medication Abortion. Health Equity. March 2025; https://doi.org/10.1089/heq.2024.0128.
  • Grossman D, Murphy EC. Expanding Access to Contraception. Obstetrics and Gynecology Clinics of North America. March 2025; https://doi.org/10.1016/j.ogc.2024.12.008.
  • Loeliger KB, Dragoman MV, Kapp N, Tamang A, Bessenaar T, Dung DL, Gautam J, Yoko JL, Minh NH, Grossman D. Factors associated with severe pain during medication abortion at ≤9 weeks’ gestation: A secondary analysis of a multicenter, randomized, placebo-controlled trial. Contraception. February 2025; https://doi.org/10.1016/j.contraception.2025.110859.
  • Grossman D. New Data on Ulipristal Acetate and Misoprostol for Medication Abortion — A Step Forward?. NEJM Evidence. January 2025; https://doi.org/10.1056/EVIDe2400460.
  • Biggs MA, Schroeder R, Kaller S, Grossman D, Scott KA, Ralph LJ. Changes in Support for Advance Provision and Over-the-Counter Access to Medication Abortion. Jama Network Open. January 2025; https://doi.org/10.1001/jamanetworkopen.2024.54767.
  • Ralph LJ, Ehrenreich K, Kaller S, Gurazada T, Biggs MA, Blanchard K, Hauser D, Kapp N, Kromenaker T, Moayedi G, Gil JP, Perritt J, Raymond EG, Taylor D, Kari White, Valladares ES, Williams S, Grossman D. Accuracy of survey-based assessment of eligibility for medication abortion compared with clinician assessment. American Journal of Obstetrics & Gynecology. January 2025; https://doi.org/10.1016/j.ajog.2025.01.008.
  • Grossman D, Murphy EC. Over-the-Counter Medication Abortion as a Strategy to Expand Access to Care. JAMA Internal Medicine. November 2024; https://doi.org/10.1001/jamainternmed.2024.6325.
  • Grossman D, Kinsey ET. Over-the-Counter Oral Contraceptives. JAMA. October 2024; https://doi.org/10.1001/jama.2024.16474.
  • Biggs MA, Ehrenreich K, Natalie Morris, MPH, Bachrach L, Crespin J, Grossman D. Young People's Support for and Personal Interest in an Advance Provision Model for Medication Abortion. Journal of Pediatric and Adolescent Gynecology. August 2024; https://doi.org/10.1016/j.jpag.2024.07.012.
  • Ralph LJ, Schroeder R, Kaller S, Grossman D, Biggs MA. Self-Managed Abortion Attempts Before vs After Changes in Federal Abortion Protections in the US. Jama Network Open. July 2024; https://doi.org/10.1001/jamanetworkopen.2024.24310.
  • Barrow A, Cohen CR, Serpico J, Goodman M, Grossman D, Raifman S, Upadhyay UD. Amicus brief of over 300 reproductive health researchers supports mifepristone's safety and effectiveness. Perspectives on Sexual and Reproductive Health. July 2024; https://doi.org/10.1111/psrh.12282.
  • Barrow A, Cohen CR, Serpico J, Goodman M, Grossman D, Raifman S, Upadhyay UD. Brief of over 300 reproductive health researchers as Amici Curiae in FDA v. Alliance for Hippocratic Medicine. Perspectives on Sexual and Reproductive Health. July 2024; https://doi.org/10.1111/psrh.12281.
  • Raifman S, Gurazada T, Beaman J, Biggs MA, Schwarz EB, Gold M, Grossman D. Primary care and abortion provider perspectives on mail-order medication abortion: a qualitative study. BMC Women's Health. July 2024; https://doi.org/10.1186/s12905-024-03202-z.
  • Krems JM, Grossman D, Ehrenreich K, Ralph LJ. Money and place: Quantifying the types of obstacles associated with seeking an abortion after 10 weeks’ gestation, 2019–2020. Contraception. July 2024; https://doi.org/10.1016/j.contraception.2024.110476.
  • Ralph LJ, Baba F, Biggs MA, McNicholas C, Miller AH, Grossman D. Comparison of No-Test Telehealth and In-Person Medication Abortion. JAMA. June 2024; https://doi.org/10.1001/jama.2024.10680.
  • Seymour JW, Melville C, Grossman D, Thompson TA. Examining service delivery patterns before and after implementation of a direct-to-patient telehealth service providing medication abortion in Australia. ANZJOG. June 2024; https://doi.org/10.1111/ajo.13846.
  • Kapp N, Romero M, Dupte S, Shaber A, Grossman D. Comprehensive Abortion Care. Oxford Research Encyclopedias. May 2024; https://doi.org/10.1093/acrefore/9780190632366.013.208.
  • Grossman D, Raifman S, Natalie Morris, MPH, Arena A, Bachrach L, Beaman J, Biggs MA, Collins A, Hannum C, Ho S, Seibold-Simpson SM, Sobota M, Tocce K, Schwarz EB, Gold M. Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening. JAMA Internal Medicine. May 2024; https://www.doi.org/10.1001/jamainternmed.2024.1476.
  • Natalie Morris, MPH, Biggs MA, Baba F, Seymour JW, Kari White, Grossman D. Interest in and Support for Alternative Models of Medication Abortion Provision Among Patients Seeking Abortion in the United States. Women's Health Issues. April 2024; https://doi.org/10.1016/j.whi.2024.03.003.
  • Filippa S, Jayaweera RT, Blanchard K, Grossman D. Do miscarriage care practice recommendations align with individuals’ needs?: a scoping review. Contraception. April 2024; https://doi.org/10.1016/j.contraception.2024.110448.
  • Biggs MA, Becker A, Schroeder R, Kaller S, Scott KA, Grossman D, Raifman S, Ralph LJ. Support for criminalization of self-managed abortion (SMA): A national representative survey. Social Science & Medicine. December 2023; https://doi.org/10.1016/j.socscimed.2023.116433.
  • Verma N, Grossman D. Obstacles to Care Mount 1 Year After Dobbs Decision. JAMA. June 2023; https://doi.org/10.1001/jama.2023.10151.
  • Ehrenreich K, Baba F, Raifman S, Grossman D. Perspectives on Alternative Models of Medication Abortion Provision Among Abortion Patients in the United States. Women's Health Issues. April 2023; https://doi.org/10.1016/j.whi.2023.03.007.
  • Ralph LJ, Biggs MA, Ehrenreich K, Grossman D. Accuracy of Self-assessment of Gestational Duration Among Adolescents Seeking Abortion Using Information in Addition to Date of Last Menstrual Period. JAMA Pediatrics. April 2023; https://doi.org/10.1001/jamapediatrics.2023.0483.
  • Roberts SCM, Claudia Zaugg, MPH, Grossman D. Health care provider reporting practices related to self-managed abortion. BMC Women's Health. March 2023; https://doi.org/10.1186/s12905-023-02266-7.
  • Verma N, Grossman D. Self-Managed Abortion in the United States. Current Obstetrics and Gynecology Reports. March 2023; https://doi.org/10.1007/s13669-023-00354-x.
  • Raymond EG, Mark A, Grossman D, Beasley A, Brandi K, Castle J, Creinin MD, Gerdts C, Gil L, Grant M, Lockley A, Perritt J, Shochet T, Truan D, Upadhyay UD. Medication abortion with misoprostol-only: A sample protocol. Contraception. February 2023; https://doi.org/10.1016/j.contraception.2023.109998.
  • Natalie Morris, MPH, Ehrenreich K, Gurazada T, Grossman D. Feasibility and Acceptability of At-Home Routine Pregnancy Testing in the United States: A Pilot Study. Women's Health Issues. February 2023; https://doi.org/10.1016/j.whi.2023.01.002.
  • Sierra G, Berglas NF, Holfer LG, Grossman D, Roberts SCM, Kari White. Out-of-State Travel for Abortion among Texas Residents following an Executive Order Suspending In-State Services during the Coronavirus Pandemic. International Journal of Environmental Research and Public Health. February 2023; https://doi.org/10.3390/ijerph20043679.
  • Baum SE, Sierra G, Grossman D, Vizcarra E, Potter JE, Kari White. Comparing preference for and use of medication abortion in Texas after policy changes in 2014 and 2018. Contraception. December 2022; https://doi.org/10.1016/j.contraception.2022.11.003.
  • Grindlay K, Key K, Bradford R, Amato C, Blanchard K, Grossman D. Pilot label comprehension study for an over-the-counter combined oral contraceptive pill in the United States. Perspectives on Sexual and Reproductive Health. November 2022; DOI: 10.1363/psrh.12214.
  • Grindlay K, Key K, Zuniga C, Wollum A, Blanchard K, Grossman D. Interest in Continued Use After Participation in a Study of Over-the-Counter Progestin-Only Pills in the United States. Women's Health Reports. November 2022; DOI: 10.1089/whr.2022.0056.
  • Grossman D, Verma N. Self-managed Abortion in the US. JAMA. November 2022; DOI: 10.1001/jama.2022.19057.
  • Ruggiero SP, Seymour JW, Thompson TA, Kohn J, Snow JL, Grossman D, Fix L. Patient and provider experiences using a site-to-site telehealth model for medication abortion. MHealth. October 2022; DOI: 10.21037/mhealth-22-12.
  • Biggs MA, Sabrina Serrano, BA, Valladares ES, Grossman D. Development of a Spanish-language drug facts label prototype for a combination mifepristone and misoprostol medication abortion product. Contraception. October 2022; DOI: 10.1016/j.contraception.2022.10.008.
  • Grindlay K, Key K, Zuniga C, Wollum A, Grossman D, Blanchard K. Experiences using a progestin-only pill in an over-the-counter environment in the United States: a cross-sectional survey. BMJ Sexual & Reproductive Health. October 2022; DOI: 10.1136/bmjsrh-2022-201637.
  • Wollum A, Zuniga C, Grindlay K, Grossman D. Who Accesses Birth Control Online? An Analysis of Requests for Contraception Submitted to an Online Prescribing Platform in the United States. Women's Health Issues. September 2022; DOI: 10.1016/j.whi.2022.08.001.
  • Grindlay K, Seymour JW, Fix L, Grossman D. Unintended Pregnancy and Abortion in the US Navy, 2016. Journal of General Internal Medicine. August 2022; DOI: 10.1007/s11606-022-07582-6.
  • Endler M, Petro G, Gemzell-Danielsson K, Grossman D, Gomperts R, Weinryb M, Constant D. A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial. The Lancet. August 2022; DOI: 10.1016/S0140-6736(22)01474-X.
  • Kaller S, Ma M, Gurazada T, Baba F, Rafie S, Raine-Bennett T, Averbach S, Chen M, Berry E, Meckstroth KR, Grossman D. "No Big Deal”: A Qualitative Study of Pharmacists’ Perspectives on Dispensing Mifepristone for Medication Abortion. Women's Health Issues. July 2022; DOI: 10.1016/j.whi.2022.06.007.
  • Grossman D. Telemedicine Provision of Medication Abortion. American Journal of Public Health. July 2022; DOI: 10.2105/AJPH.2022.306995.
  • Verma N, Goyal V, Grossman D, Perritt J, Shih G. Society of Family Planning interim clinical recommendations: Self-managed abortion. Society of Family Planning. July 2022.
  • Grossman D, Perritt J, Grady D. The Impending Crisis of Access to Safe Abortion Care in the US. JAMA Internal Medicine. June 2022; doi:10.1001/jamainternmed.2022.2893.
  • Seymour JW, Melville C, Thompson TA, Grossman D. Effectiveness and safety of a direct-to-patient telehealth service providing medication abortion targeted at rural and remote populations: Cross-sectional findings from Marie Stopes Australia. Contraception. June 2022; DOI: 10.1016/j.contraception.2022.06.010.
  • Biggs MA, Ehrenreich K, Natalie Morris, MPH, Blanchard K, Bustamante CK, Choimorrow SY, Hauser D, Hernandez Y, Kapp N, Kromenaker T, Moayedi G, Perritt J, Ralph LJ, Raymond EG, Valladares ES, Kari White, Grossman D. Comprehension of an Over-the-Counter Drug Facts Label Prototype for a Mifepristone and Misoprostol Medication Abortion Product. Obstetrics & Gynecology. May 2022; DOI: 10.1097/AOG.0000000000004757.
  • Dickman SL, Kari White, Sierra G, Grossman D. Financial Hardships Caused by Out-of-Pocket Abortion Costs in Texas, 2018. American Journal of Public Health. March 2022; DOI: 10.2105/AJPH.2021.306701.
  • Biggs MA, Ralph LJ, Natalie Morris, MPH, Ehrenreich K, Perritt J, Kapp N, Blanchard K, Kari White, Barar RE, Grossman D. A cross-sectional survey of U.S. abortion patients’ interest in obtaining medication abortion over the counter. Contraception. January 2022; DOI: 10.1016/j.contraception.2022.01.010.
  • Adams M, Kully G, Tilford S, Kari White, Mody S, Hildebrand M, Johns N, Grossman D, Averbach S. Time from first clinical contact to abortion in Texas and California. Contraception. December 2021; doi: 10.1016/j.contraception.2021.12.009.
  • Ralph LJ, Ehrenreich K, Barar RE, Biggs MA, Natalie Morris, MPH, Blanchard K, Kapp N, Moayedi G, Perritt J, Raymond EG, Kari White, Grossman D. Accuracy of self-assessment of gestational duration among people seeking abortion. American Journal of Obstetrics & Gynecology. December 2021; doi: 10.1016/j.ajog.2021.11.1373.
  • Ehrenreich K, Biggs MA, Grossman D. Making the case for advance provision of mifepristone and misoprostol for abortion in the United States. BMJ Sexual & Reproductive Health. December 2021; doi: 10.1136/bmjsrh-2021-201321.
  • Grossman D, Raifman S, Natalie Morris, MPH, Arena A, Bachrach L, Beaman J, Biggs MA, Hannum C, Ho S, Schwarz EB, Gold M. Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment. Contraception. October 2021; DOI: 10.1016/j.contraception.2021.09.008.
  • Upadhyay UD, Cartwright AF, Grossman D. Barriers to abortion care and incidence of attempted self-managed abortion among individuals searching Google for abortion care: A national prospective study. Contraception. September 2021; DOI: 10.1016/j.contraception.2021.09.009.
  • Thompson TA, Seymour JW, Melville C, Khan Z, Danielle Mazza, Grossman D. An observational study of patient experiences with a direct-to-patient telehealth abortion model in Australia. BMJ Sexual & Reproductive Health. September 2021; doi: 10.1136/bmjsrh-2021-201259.
  • Dickman SL, Kari White, Grossman D. Affordability and Access to Abortion Care in the United States. JAMA Internal Medicine. July 2021; [Epub ahead of print].
  • Whitehouse KC, Stifani BM, Duffy JMN, Kim CR, Creinin MD, DePiñeres T, Beverly Winikoff, Gemzell-Danielsson K, Blum J, Renee Bracey Sherman, Lavelanet AF, Brahmi D, Grossman D, Tamang A, Gebreselassie H, Ponce de Leon RG, Ganatra B. Standardizing abortion research outcomes (STAR): Results from an international consensus development study. Contraception. July 2021; S0010-7824(21)00224-9. doi: 10.1016/j.contraception.2021.07.004. Epub ahead of print.
  • Roberts SCM, Berglas NF, Schroeder R, Grossman D, Lingwall M, Kari White. Disruptions to Abortion Care in Louisiana During Early Months of the COVID-19 Pandemic. American Journal of Public Health. June 2021; e1-e9.
  • Kaller S, Natalie Morris, MPH, Biggs MA, Baba F, Rafie S, Raine-Bennett T, Creinin MD, Berry E, Micks EA, Meckstroth KR, Averbach S, Grossman D. Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion. Journal of the American Pharmacists Association. June 2021; S1544-3191(21)00285-5. [Epub ahead of print].
  • Potter JE, Burke KL, Broussard K, Hopkins K, Grossman D, Kari White. Improving Assessment of Demand for Postpartum Tubal Ligation among Publicly Insured Women in Texas. Contraception. May 2021; S0010-7824(21)00156-6. [Epub ahead of print].
  • Grossman D, Constant D, Lopes S. Could routine pregnancy self-testing facilitate earlier recognition of unintended pregnancy? A feasibility study among South African women. BMJ Sexual & Reproductive Health. May 2021; [Epub ahead of print].
  • Raifman S, Ralph LJ, Biggs MA, Grossman D. “I’ll just deal with this on my own”: a qualitative exploration of experiences with self-managed abortion in the United States. Reproductive Health. May 2021; 2021; 18:91.
  • Coleman-Minahan K, Ela EJ, Kari White, Grossman D. Contraindications to hormonal contraception among postpartum women in Texas. Obstetrics & Gynecology. April 2021; [Epub ahead of print].
  • Kaller S, Daniel S, Raifman S, Biggs MA, Grossman D. Pre-abortion informed consent through telemedicine vs. in person: Differences in patient demographics and visit satisfaction. Women's Health Issues. April 2021; [Epub ahead of print].
  • Daniel S, Schulkin J, Grossman D. Obstetrician-gynecologist willingness to provide medication abortion with removal of the in-person dispensing requirement for mifepristone. Contraception. March 2021; [Epub ahead of print].
  • Raifman S, Baum SE, Kari White, Hopkins K, Ogburn T, Grossman D. Perspectives on self-managed abortion among providers in hospitals along the Texas-Mexico border. BMC Women's Health. March 2021; 21:132.
  • Raifman S, Sierra G, Grossman D, Baum SE, Hopkins K, Potter JE, Kari White. Border-state abortions increased for Texas residents after House Bill 2. Contraception. March 2021; [Epub ahead of print].
  • Raifman S, Biggs MA, Ralph LJ, Ehrenreich K, Grossman D. Exploring attitudes about the legality of self managed abortion in the US: Results from a nationally representative survey. Journal of Sexuality Research and Social Policy. March 2021; [Epub ahead of print].
  • Grossman D, Baba F, Kaller S, Biggs MA, Raifman S, Gurazada T, Rafie S, Averbach S, Meckstroth KR, Micks EA, Berry E, Raine-Bennett T, Creinin MD. Medication abortion with pharmacist dispensing of mifepristone. Obstetrics & Gynecology. March 2021; [Epub ahead of print].
  • Constant D, Endler M, Grossman D, Petro G, Patel M. Immediate versus delayed insertion of the copper intrauterine device after medical abortion at 17-20 gestational weeks: a randomised controlled trial. BMJ Sexual & Reproductive Health. February 2021; Epub ahead of print.
  • Dragoman MV, Grossman D, Nguyen MH, Habib N, Kapp N, Tamang A, Bessenaar T, Duong LD, Gautam J, Yoko JL, Hong M, Gulmezoglu M. Two prophylactic pain management regimens for medical abortion ≤63 days' gestation with mifepristone and misoprostol: A multicenter, randomized, placebo-controlled trial. Contraception. January 2021; 103(3):163-170.
  • Grindlay K, Wollum A, Karver J, Grossman D. Over-the-counter oral contraceptive use among women in Mexico: results from a national survey. BMJ Sexual & Reproductive Health. January 2021; [Epub ahead of print].
  • White K, Bhavik Kumar, Goyal V, Wallace RR, Roberts SCM, Grossman D. Changes in abortion in Texas following an executive order ban during the coronavirus pandemic. JAMA Internal Medicine. January 2021; 325(7):691-693.
  • Kohn JE, Snow JL, Grossman D, Thompson TA, Seymour JW, Simons HR. Introduction of telemedicine for medication abortion: changes in service delivery patterns in two U.S. states. Contraception. December 2020; 103(3):151-156.
  • Ralph LJ, Foster DG, Biggs MA, Samari G, Upadhyay UD, Gerdts C, Grossman D. Prevalence of self-managed abortion among women of reproductive age in the United States. JAMA. December 2020; 3(12):e2029245.
  • Wollum A, Zuniga C, Lezama N, Grossman D, Grindlay K. A randomized study evaluating the effect of evidence-based information on clinician attitudes about moving oral contraceptives over the counter. Journal of Women's Health. December 2020; jwh.2020.8706.
  • Grossman D. Increasing Access to Abortion: ACOG Committee Opinion, Number 815. Obstetrics & Gynecology. December 2020; 136(6):e107-e115.
  • Creinin MD, Grossman D, Committee on Practice Bulletins—Gynecology, Society of Family Planning. Medication abortion up to 70 days of gestation: ACOG practice bulletin, number 225. Obstetrics & Gynecology. October 2020; 136(4):e31-e47.
  • Daniel S, Schulkin J, Grossman D. Abortion referral practices among a national sample of obstetrician-gynecologists. Women's Health Issues. September 2020; 30(6):446-452.
  • Castleberry NM, Stark L, Schulkin J, Grossman D. Oral and IUD emergency contraception provision among a national sample of obstetrician-gynecologists. Contraception. September 2020; 102(6):406-408.
  • Seymour JW, Fix L, Grossman D, Grindlay K. Pregnancy and abortion: Experiences and attitudes of deployed U.S. servicewomen. Military Medicine. August 2020; usaa128.
  • Landau C, Sella S, Grossman D. Mifepristone–misoprostol versus misoprostol-alone regimen for medication abortion at 24 weeks’ gestation. Contraception. May 2020; 102(2):99-103.
  • Thompson TA, Sonalkar S, Butler JL, Grossman D. Telemedicine for family planning: A scoping review. Obstetrics and Gynecology Clinics of North America. April 2020; 47(2):287-316. doi: 10.1016/j.ogc.2020.02.004.
  • Seymour JW, Fix L, Grossman D, Grindlay K. Contraceptive use and access among deployed US servicewomen: Findings from an online survey. BMJ Sexual & Reproductive Health. April 2020; 47:61-66.
  • Raymond EG, Grossman D, Mark A, Upadhyay UD, Dean G, Creinin MD, Coplon L, Perritt J, Atrio JM, Taylor D, Gold M. Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond. Contraception. April 2020; 101(6):361–366.
  • Harris LH, Grossman D. Complications of Unsafe and Self-Managed Abortion. New England Journal of Medicine. March 2020; 382:1029-1040.
  • Wollum A, Trussell J, Grossman D, Grindlay K. Modeling the Impacts of Price of an Over-the-Counter Progestin-Only Pill on Use and Unintended Pregnancy Among U.S. Women. Women's Health Issues. February 2020; 30(3):153-160.
  • Mark A, Grossman D, Foster AM, Prager SW, Beverly Winikoff. When patients change their minds after starting an abortion: Guidance from the National Abortion Federation's Clinical Policies Committee. Contraception. February 2020; 101(5):283–5.
  • DeNicola N, Grossman D, Marko K, Sonalkar S, Butler Tobah YS, Ganju N, Witkop CT, Henderson JT, Butler JL, Lowery C. Telehealth Interventions to Improve Obstetric and Gynecologic Health Outcomes: A Systematic Review. Obstetrics & Gynecology. January 2020; 135(2):371-382.
  • Fuentes L, Baum SE, Keefe-Oates B, White K, Hopkins K, Potter JE, Grossman D. Texas women’s decisions and experiences regarding self-managed abortion. BMC Women's Health. January 2020; 20:6.
  • Daniel S, Kaller S, Grossman D. Characteristics of patients having telemedicine versus in-person informed consent visits before abortion in Utah. Contraception. January 2020; 101(1):56-61.
  • Fix L, Seymour JW, Grossman D, Johnson DM, Aiken AR, Gomparts R, Grindlay K. Abortion need among U.S. servicewomen: Evidence from an internet service. Women's Health Issues. December 2019; 30(3):161-166.
  • Biggs MA, Casas L, Ramm A, Correa SV, Grossman D. Future health providers’ willingness to provide abortion services following decriminalisation of abortion in Chile: a cross-sectional survey. BMJ Open. October 2019; 9:e030797.
  • Grossman D, Bessenaar T, Duong LD, Tamang A, Dragoman MV. Experiences with pain of early medical abortion: qualitative results from Nepal, South Africa, and Vietnam. BMC Women's Health. October 2019; 19:118.
  • Ehrenreich K, Kriz R, Grossman D. Miscarriage information available on the internet: a content analysis of leading consumer websites. Contraception: X. October 2019; 1(2019):100010.
  • Moseson H, Filippa S, Baum SE, Gerdts C, Grossman D. Reducing underreporting of stigmatized pregnancy outcomes: results from a mixed-methods study of self-managed abortion in Texas using the list-experiment method. BMC Women's Health. September 2019; 19(1):113.
  • Constant D, Kluge J, Harries J, Grossman D. An analysis of delays among women accessing second-trimester abortion in the public sector in South Africa. Contraception. September 2019; 100(3):209-213.
  • Ehrenreich K, Kaller S, Grossman D. Women's Experiences Using Telemedicine to Attend Abortion Information Visits in Utah: A Qualitative Study. Women's Health Issues. September 2019; Volume 29, Issue 5, Pages 407–413.
  • Upadhyay UD, Grossman D. Telemedicine for medication abortion. Contraception. August 2019; 100(5):351-353.
  • Kohn JE, Snow JL, Simons HR, Seymour JW, Thompson TA, Grossman D. Medication Abortion Provided Through Telemedicine in Four U.S. States. Obstetrics & Gynecology. August 2019; 134(2):343-350.
  • Castleberry NM, Stark L, Schulkin J, Grossman D. Implementing best practices for the provision of long-acting reversible contraception: a survey of obstetrician-gynecologists. Contraception. August 2019; 100(2):123-127.
  • Grossman D. Telemedicine for medical abortion—Time to move towards broad implementation. BJOG: An International Journal of Obstetrics & Gynaecology. August 2019; 126(9):1103.
  • Grossman D. Expanding Access to Short-Acting Hormonal Contraceptive Methods in the United States. JAMA Internal Medicine. July 2019; 179(9):1209-1210.
  • Ralph LJ, Schwarz EB, Grossman D, Foster DG. Self-reported Physical Health of Women Who Did and Did Not Terminate Pregnancy After Seeking Abortion Services: A Cohort Study. Annals of Internal Medicine. June 2019; 171(4):238-247.
  • Mark A, Foster AM, Grossman D, Prager SW, Reeves M, Velásquez CV, Beverly Winikoff. Foregoing Rh testing and anti-D immunoglobulin for women presenting for early abortion: a recommendation from the National Abortion Federation's Clinical Policies Committee. Contraception. May 2019; 99(5):265-266.
  • Baum SE, White K, Hopkins K, Potter JE, Grossman D. Rebound of medication abortion in Texas following updated mifepristone label. Contraception. May 2019; 99(5):278-280.
  • Seymour JW, Fix L, Grossman D, Grindlay K. Facilitators and Barriers to Contraceptive Use Among U.S. Servicewomen Who Had an Abortion. Military Medicine. May 2019; 184(5-6):e417–e423.
  • Kohn JE, Snow JL, Simons HR, Seymour JW, Thompson TA, Grossman D. Safety and effectiveness of medication abortion provided via telemedicine at Planned Parenthood in four U.S. states. Contraception. May 2019; 99(5):317.
  • White K, Baum SE, Hopkins K, Potter JE, Grossman D. Change in Second-Trimester Abortion After Implementation of a Restrictive State Law. Obstetrics & Gynecology. April 2019; 133(4):771-779.
  • Potter JE, Stevenson AJ, Coleman-Minahan K, Hopkins K, White K, Baum SE, Grossman D. Challenging unintended pregnancy as an Indicator of reproductive autonomy. Contraception. March 2019; 100(1):1-4.
  • Grossman D, Grindlay K, Altshuler AL, Schulkin J. Induced Abortion Provision Among a National Sample of Obstetrician–Gynecologists. Obstetrics & Gynecology. March 2019; 133(3):477-483.
  • Lince-Deroche N, Harries J, Constant D, Morroni D, Pleaner M, Fetters T, Grossman D, Blanchard K, Sinanovic E. Doing more for less: identifying opportunities to expand public sector access to safe abortion in South Africa through budget impact analysis. Contraception. February 2019; 97(2):167-176.
  • Biggs MA, Ralph LJ, Foster DG, Grossman D. Support for and interest in alternative models of medication abortion provision among a national probability sample of U.S. women. Contraception. February 2019; 99(2):118-124.
  • Zuniga C, Grossman D, Harrell S, Blanchard K, Grindlay K. Breaking down barriers to birth control access: An assessment of online platforms prescribing birth control in the USA. Journal of Telemedicine and Telecare. January 2019; 26(6):322-331.
  • Grossman D, White K. Abortion “Reversal” — Legislating without Evidence. New England Journal of Medicine. October 2018; 379:1491-1493.
  • Orlando M, Rafie S, Grossman D. Medication abortion: Potential for improved patient access through pharmacies. Journal of the American Pharmacists Association. July 2018; 58(4):377–381.
  • Lince-Deroche N, Constant D, Harries J, Kluge J, Blanchard K, Sinanovic E, Grossman D. The costs and cost effectiveness of providing second-trimester medical and surgical safe abortion services in Western Cape Province, South Africa. PLOS One. July 2018; 13(6):e0197485.
  • Hopkins K, Hubert C, Coleman-Minahan K, Stevenson AJ, White K, Grossman D, Potter JE. Unmet demand for short-acting hormonal and long-acting reversible contraception among community college students in Texas.. Journal of American College Health. July 2018; 66(5):360-8.
  • Anderson P, Kaller S, Tober D, Grossman D. Evaluating the capacity of California's publicly funded universities to provide medication abortion. Contraception. June 2018; 98(4):306-311.
  • Grindlay K, Grossman D. Interest in over-the-counter access to a progestin-only pill among women in the United States. Women's Health Issues. March 2018; 28(2):144-151.
  • Rocca CH, Puri M, Shrestha P, Blum M, Maharjan D, Grossman D, Regmi K, Darney PD, Harper CC. Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: A non-inferiority study in Nepal. PLOS One. January 2018; 13(1):e0191174.
  • Rocca CH, Goodman S, Grossman D, Cadwaller K, Thompson KMJ, Talmont E, Speidel JJ, Harper CC. Contraception after medication abortion in the United States: results from a cluster randomized trial. American Journal of Obstetrics & Gynecology. January 2018; 218(1):107.e1-107.e8.
  • Grossman D, Baum SE, Andjelic D, Tatum C, Torres G, Fuentes L, Friedman J. A harm-reduction model of abortion counseling about misoprostol use in Peru with telephone and in-person follow-up: A cohort study. PLOS One. January 2018; https://doi.org/10.1371/journal.pone.0189195.
  • White K, Grossman D, Stevenson AJ, Hopkins K, Potter JE. Does information about abortion safety affect Texas voters' opinions about restrictive laws? A randomized study. Contraception. December 2017; 96(6):381-387.
  • Grindlay K, Seymour JW, Fix L, Reiger S, Keefe-Oates B, Grossman D. Abortion Knowledge and Experiences Among U.S. Servicewomen: A Qualitative Study. Perspectives on Sexual and Reproductive Health. November 2017; doi:10.1363/psrh.12044.
  • Vu K, Rafie S, Grindlay K, Gutierrez H, Grossman D. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California. Journal of Pharmacy Practice. November 2017; 32(1):54-61.
  • White K, Grossman D, Potter JE. Providing family planning services at primary care organizations after the exclusion of Planned Parenthood from publicly funded programs in Texas: early qualitative evidence.. Health Services Research. October 2017; 53(S1):2770-2786.
  • Rocca CH, Goodman S, Grossman D, Cadwallader K, Thompson KM, Talmont E, Speidel JJ, Harper CC. Contraception after medication abortion in the United States: Results from a cluster randomized trial. American Journal of Obstetrics & Gynecology. October 2017; 218(1):107.e1-107.e8.
  • Kapp N, Grossman D, Jackson E, Castleman L, Brahmi D. A research agenda for moving early medical pregnancy termination over the counter. BJOG: An International Journal of Obstetrics & Gynaecology. October 2017; 124(11):1646-1652.
  • Grossman D, Grindlay K. Safety of Medical Abortion Provided Through Telemedicine Compared With in Person. Obstetrics & Gynecology. September 2017; 130(4):778-782.
  • White K, Turan JM, Grossman D. Travel for Abortion Services in Alabama and Delays Obtaining Care. Women's Health Issues. September 2017; 27(5):523-529.
  • Potter JE, Coleman-Minahan K, White K, Powers DE, Dillaway C, Stevenson AJ, Hopkins K, Grossman D. Contraception After Delivery among Publicly Insured Women in Texas: Use compared with Preference. Obstetrics & Gynecology. August 2017; 130(2):393-402.
  • Grindlay K, Grossman D. Telemedicine provision of medical abortion in Alaska: Through the provider’s lens. Journal of Telemedicine and Telecare. August 2017; 23(7):680-685.
  • White K, Campbell A, Hopkins K, Grossman D, Potter JE. Barriers to Offering Vasectomy at Publicly Funded Family Planning Organizations in Texas. Am J Mens Health. May 2017; 11(3):757-766.
  • Grossman D. Sexual and reproductive health under the Trump presidency: policy change threatens women in the USA and worldwide. Journal of Family Planning and Reproductive Health Care. April 2017; 43(2):89-91.
  • Cohen CR, Grossman D, Onono M, Blat C, Newmann SJ, Burger RL, Shade SB, Bett N, Bukusi EA. Integration of family planning services into HIV care clinics: Results one year after a cluster randomized controlled trial in Kenya. PLOS One. March 2017; 22;12(3):e0172992.
  • Raymond EG, Blanchard K, Blumenthal PD, Cleland K, Foster AM, Gold M, Grossman D, Pendergast MK, Westhoff CL, Beverly Winikoff. Sixteen Years of Overregulation: Time to Unburden Mifeprex. New England Journal of Medicine. February 2017; 376:790-794.
  • Grossman D. The Use of Public Health Evidence in Whole Woman’s Health v Hellerstedt. JAMA Internal Medicine. February 2017; 177(2):155-156.
  • Grossman D, White K, Hopkins K, Potter JE. Change in Distance to Nearest Facility and Abortion in Texas, 2012 to 2014. Journal of the American Medical Association. January 2017; 317(4):437-439.
  • White K, Potter JE, Stevenson AJ, Fuentes L, Hopkins K, Grossman D. Women’s knowledge of and support for abortion restrictions in Texas: Findings from a statewide representative survey. Perspectives on Sexual and Reproductive Health. December 2016; 48(4):189-197.
  • Grossman D, Grindlay K, Burns B. Public funding for abortion where broadly legal. Contraception. November 2016; 94(5):453–460.
  • Baum SE, White K, Hopkins K, Potter JE, Grossman D. Women’s Experience Obtaining Abortion Care in Texas after Implementation of Restrictive Abortion Laws: A Qualitative Study. PLOS One. October 2016.
  • Dragoman MV, Grossman D, Kapp N, Tamang A, Huong NM, Habib N, Dung DL. Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days' gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial. Reproductive Health. October 2016; 13(1):132.
  • Constant D, Harries J, Malaba T, Myer L, Patel M, Petro G, Grossman D. Clinical Outcomes and Women’s Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa. PLOS One. September 2016; 11(9):e0161843.
  • Newmann SJ, Rocca CH, Jennifer Monroe Zakaras, Onono M, Bukusi EA, Grossman D, Cohen CR. Does Integrating Family Planning into HIV Services Improve Gender Equitable Attitudes? Results from a Cluster Randomized Trial in Nyanza, Kenya. AIDS and Behavior. September 2016; 20(9):1883-92.
  • Hubert C, White K, Hopkins K, Grossman D, Potter JE. Perceived interest in vasectomy among Latina women and their partners in a community with limited access to female sterilization. J Health Care Poor Underserved. May 2016; 27(2):762-77.
  • Fuentes L, Lebenkoff S, White K, Gerdts C, Hopkins K, Potter JE, Grossman D. Women’s experiences seeking abortion care shortly after the closure of clinics due to a restrictive law in Texas. Contraception. April 2016; 93(4):292-7.
  • Gerdts C, Fuentes L, Grossman D, White K, Keefe-Oates B, Baum SE, Hopkins K, Stolp CW, Potter JE. Impact of Clinic Closures on Women Obtaining Abortion Services After Implementation of a Restrictive Law in Texas. American Journal of Public Health. March 2016; 106(5):857-64.
  • Norris A, Harrington BJ, Grossman D, Hemed M, Hindin M. Abortion experiences among Zanzibari women: a chain-referral sampling study. Reproductive Health. March 2016; 13(1):23.
  • Grindlay K, Grossman D. Prescription Birth Control Access Among U.S. Women at Risk of Unintended Pregnancy. Journal of Women's Health. March 2016; 25(3):249-54.
  • Baum SE, Burns B, Davis L, Miriam Yeung, Scott C, Grindlay K, Grossman D. Perspectives among a Diverse Sample of Women on the Possibility of Obtaining Oral Contraceptives Over the Counter: A Qualitative Study. Women's Health Issues. March 2016; 26(2):147-52.
  • White K, deMartelly V, Grossman D, Turan JM. Experiences Accessing Abortion Care in Alabama among Women Traveling for Services. Women's Health Issues. February 2016; 26(3):298-304.
  • Newmann SJ, Jennifer Monroe Zakaras, Tao AR, Onono M, Bukusi EA, Cohen CR, Steinfeld R, Grossman D. Integrating family planning into HIV care in western Kenya: HIV care providers' perspectives and experiences one year following integration. AIDS Care. February 2016; 28(2):209-13.
  • Potter JE, Hubert C, Stevenson AJ, Hopkins K, Aiken AR, White K, Grossman D. Barriers to Postpartum Contraception in Texas and Pregnancy Within 2 Years of Delivery. Obstetrics & Gynecology. February 2016; 127(2):289-96.
  • Grindlay K, Grossman D. Pregnancy among Active-Duty Women in the United States Military, 2011. Contraception. December 2015; 92(6):589-95.
  • Grossman D. Over-the-Counter Access to Oral Contraceptives. Obstetrics and Gynecology Clinics of North America. December 2015; 42:619-29.
  • Grossman D. The Potential Impact of Over-the-Counter Access to Oral Contraceptives to Reduce Unintended Pregnancy. American Family Physician. December 2015; 92(11):968-9.
  • Grossman D, Goldstone P. Mifepristone by prescription: a dream in the United States but reality in Australia. Contraception. September 2015; 92(3):186-9.
  • Raymond EG, Grossman D, Weibe E, Beverly Winikoff. Reaching women where they are: eliminating the initial in-person medical abortion visit. Contraception. September 2015; 92(3):190-3.
  • Dzuba LG, Grossman D, Schreiber CA. Off-label indications for mifepristone in gynecology and obstetrics. Contraception. September 2015; 92(3):203-205.
  • Grossman D, White K, Harris L, Reeves M, Blumenthal PD, Beverly Winikoff, David A. Grimes. Continuing pregnancy after mifepristone and "reversal" of first-trimester medical abortion: a systematic review. Contraception. September 2015; 92(3):206-11.
  • Hopkins K, White K, Linkin F, Hubert C, Grossman D, Potter JE. Women's experiences seeking publicly funded family planning services in Texas. Perspectives on Sexual and Reproductive Health. June 2015; 47(2):63-70.
  • White K, Hopkins K, Aiken AR, Stevenson AJ, Hubert C, Grossman D, Potter JE. The impact of reproductive health legislation on family planning clinic services in Texas. American Journal of Public Health. May 2015; 105(5):851-8.
  • Foster DG, Biggs MA, Phillips KA, Grindlay K, Grossman D. Potential public sector cost-savings from over-the-counter access to oral contraceptives. Contraception. May 2015; 91(5):373-9.
  • Biggs MA, Rocca CH, Brindis CD, Hirsch H, Grossman D. Did Increasing Use of Highly Effective Contraception Contribute to Declining Abortions in Iowa?. Contraception. February 2015.
  • Upadhyay UD, Desai S, Zlidar V, Weitz TA, Grossman D, Anderson P, Taylor D. Incidence of Emergency Department Visits and Complications After Abortion. Obstetrics & Gynecology. January 2015; 125(1):175-83.
  • Foster DG, Grossman D, Turok DK, Peipert JF, Prine L, Shreiber CA, Jackson AV, Barar RE, Schwarz EB. Interest in and experience with IUD self-removal. Contraception. July 2014; 90(1):54-9.
  • Grindlay K, Foster DG, Grossman D. Attitudes toward over-the-counter access to oral contraceptives among a sample of abortion clients in the United States. Perspectives on Sexual and Reproductive Health. June 2014; 46(2):83-9.
  • Foster DG, Karasek D, Grossman D, Darney PD, Scharz EB. Interest in using intrauterine contraception when the option of self-removal is provided. October 2013.
  • Cockrill K, Herold S, Upadhyay UD, Baum SE, Blanchard K, Grossman D. Addressing Abortion Stigma Through Service Delivery: A White Paper. September 2013.
  • Foster DG, Biggs MA, Grossman D, Schwarz EB. Interest in a Pericoital Pill Among Women in Family Planning and Abortion Clinics. Contraception. July 2013.
  • Grindlay K, Lane K, Grossman D. Women's and providers' experiences with medical abortion provided through telemedicine: A qualitative study. Women's Health Issues. March 2013; 23(2):e117-22.
  • Grossman D, Grindlay K, Buchacker T, Potter JE, Schmertmann CP. Changes in service delivery patterns after introduction of telemedicine provision of medical abortion in Iowa. American Journal of Public Health. January 2013; 103(1): 73-78.
  • Lessard LN, Karasek D, Ma S, Darney PD, Deardorff J, Lahiff M, Grossman D, Foster DG. Contraceptive Features Preferred by Women at High Risk of Unintended Pregnancy. Perspectives on Sexual and Reproductive Health. July 2012.
  • Grossman D, Grindlay K, Buchacker T, Lane K, Blanchard K. Effectiveness and acceptability of medical abortion provided through telemedicine. Obstetrics & Gynecology. August 2011; 118(2):296-303.
  • Phillips KA, Grossman D, Weitz TA, Trussell J. Bringing evidence to the debate on abortion coverage in health reform legislation: findings from a national survey in the United States. Contraception. August 2010; 82(2010):129–130.

The latest research

See all
April 13, 2026

Examining the association between prior medical mistreatment and interest in and support for over-the-counter medication abortion among people seeking in-person abortion in the United States

Get citation
December 19, 2025

Lessons learned from the movement behind the first over-the-counter daily birth control pill in the United States and recommended strategies for implementing full insurance coverage

Get citation

News

See all

Ongoing studies

See all